BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7732331)

  • 1. Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer.
    Hotz J; Plein K; Schönekäs H; Rose K
    Scand J Gastroenterol; 1995 Feb; 30(2):111-5. PubMed ID: 7732331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group.
    Judmaier G; Koelz HR
    Aliment Pharmacol Ther; 1994 Feb; 8(1):81-6. PubMed ID: 8186350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.
    Cremer M; Lambert R; Lamers CB; Delle Fave G; Maier C
    Dig Dis Sci; 1995 Jun; 40(6):1360-4. PubMed ID: 7781461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A; Wiseman L
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of pantoprazole compared with ranitidine.
    Bader JP; Delchier JC
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():47-52. PubMed ID: 8180294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of duodenal ulcer with pantoprazole. A multicenter study].
    Fric P; Huslarová A; Dítĕ P; Jirásek V; Roth Z; Svoboda J; Drazná E; Dufek V; Dvorák M; Kunovská M; Münzová H; Pelech T; Petrtýl J; Zádorová Z; Zavoral M
    Cas Lek Cesk; 1996 Dec; 135(23):758-61. PubMed ID: 9005122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer.
    Chen TS; Chang FY; Ng WW; Lee FY; Hwang SJ; Lee SD
    Hepatogastroenterology; 1999; 46(28):2372-8. PubMed ID: 10522000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
    Schepp W; Rehner M; Witzel L
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
    Dettmer A; Vogt R; Sielaff F; Lühmann R; Schneider A; Fischer R
    Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
    Witzel L; Gütz H; Hüttemann W; Schepp W
    Aliment Pharmacol Ther; 1995 Feb; 9(1):19-24. PubMed ID: 7766739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
    Koop H; Schepp W; Dammann HG; Schneider A; Lühmann R; Classen M
    J Clin Gastroenterol; 1995 Apr; 20(3):192-5. PubMed ID: 7797824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
    Schepp W; Classen M
    Scand J Gastroenterol; 1995 Jun; 30(6):511-4. PubMed ID: 7569755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
    Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Superiority of pantoprazole over ranitidine in the treatment of duodenal ulcer. Mexican clinical experience. Mexican Study Group of Pantoprazole++ in Duodenal Ulcer].
    Dibildox M; Rose K; Tomás-Pons J; Fischer R; Gallo S
    Rev Gastroenterol Mex; 1996; 61(3):193-8. PubMed ID: 9102740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effectiveness of pantoprazole and ranitidine in the treatment of duodenal ulcer. Result of an international multicenter study].
    Papp J; Döbrönte Z; Juhász L; Lonovics J
    Orv Hetil; 1997 Nov; 138(45):2863-6. PubMed ID: 9432635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
    Brunner G; Harke U
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():59-64. PubMed ID: 8180296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil.
    Meneghelli UG; Zaterka S; de Paula Castro L; Malafaia O; Lyra LG
    Am J Gastroenterol; 2000 Jan; 95(1):62-6. PubMed ID: 10638560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.
    van Rensburg CJ; Honiball PJ; Grundling HD; van Zyl JH; Spies SK; Eloff FP; Simjee AE; Segal I; Botha JF; Cariem AK; Marks IN; Theron I; Bethke TD
    Aliment Pharmacol Ther; 1996 Jun; 10(3):397-401. PubMed ID: 8791969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.